Literature DB >> 7540845

Adhesion co-receptor expression and intracellular signalling in HIV disease: implications for immunotherapy.

T T Ng1, C Guntermann, K E Nye, J M Parkin, J Anderson, J E Norman, W J Morrow.   

Abstract

OBJECTIVES: To investigate, in lymphocytes from HIV-1-infected individuals, the phenotypic expression of various adhesion co- or counter-receptors [lymphocyte function-associated antigen (LFA)-3, LFA-1 and intercellular adhesion molecule (ICAM)-1] involved in providing the co-stimulatory signal through the phospholipase C-gamma pathway in relation to inositol polyphosphate metabolism. DESIGN AND METHODS: Cell adhesion molecule profiles of peripheral blood lymphocytes (PBL) from 39 HIV-1-infected individuals at various stages of infection and 20 healthy laboratory controls were studied using flow cytometry. These were studied in 14 patients with late-stage disease in conjunction with their inositol polyphosphate metabolic profiles measured by high performance liquid chromatography. Levels of HIV-1 present in cell lysates were concurrently measured by a p24 antigen capture assay. In addition, the effects of a specific anti-ICAM-1 antisense oligonucleotide on the intracellular phosphatase activities of lymphocytes from a separate group of eight HIV-1-infected individuals were examined.
RESULTS: The expression of LFA-1, a beta 2 integrin, was upregulated among patient PBL in parallel with disease progression, whereas that of LFA-3 (CD58) was found to be significantly reduced among the CD4+ lymphocyte subset in all stages of infection. The 5-phosphatase activity, which we previously observed to be defective in HIV disease, was found to correlate linearly with the expression of both LFA-1 and its ligand, ICAM-1. Treatment of patient lymphocytes with an antisense oligonucleotide, which reduced the cell surface expression of ICAM-1 by blocking the translation of its mRNA, resulted in further reduction of intracellular phosphatase activities.
CONCLUSIONS: Our results suggest a pivotal role for adhesion co- and counter-receptors in influencing lymphocyte signalling and hence cellular response to recall antigens in HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540845

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

2.  Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells.

Authors:  Marie-Paule Carreno; Nicolas Chomont; Michel D Kazatchkine; Theano Irinopoulou; Corrine Krief; Ali-Si Mohamed; Laurent Andreoletti; Mathieu Matta; Laurent Belec
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones.

Authors:  S J Fidler; L Dorrell; S Ball; G Lombardi; J Weber; C Hawrylowicz; A D Rees
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

4.  Antibody against integrin lymphocyte function-associated antigen 1 inhibits HIV type 1 infection in primary cells through caspase-8-mediated apoptosis.

Authors:  Tiffany N Walker; Lisa M Cimakasky; Ebony M Coleman; M Nia Madison; James E K Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-20       Impact factor: 2.205

5.  Asymptomatic simian immunodeficiency virus infection decreases blood CD4(+) T cells by accumulating recirculating lymphocytes in the lymphoid tissues.

Authors:  A R Schenkel; H Uno; C D Pauza
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Expression of adhesion molecules and CD28 on T lymphocytes during human immunodeficiency virus infection.

Authors:  S W Park; W Royal; R D Semba; G W Wiegand; D E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

7.  LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20.

Authors:  Mélanie R Tardif; Caroline Gilbert; Sandra Thibault; Jean-François Fortin; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.